BioGaia News February 2010

Year-end report: Impressive 2009 BioGaia increased net sales 40 per cent to SEK 203.5 million from SEK 145.2 million in 2008. The operating profit was SEK 47.7 million, an improvement of SEK 21.9 million. The sales of BioGaia's finished consumer products in Europe accounted for most of the sales increase compared to last year. Of total finished consumer products, 31% were sold under the BioGaia brand compared to 21% last year. "Both the rapid growth in sales and profit and the enthusiastic reception our products have received in all of the new countries where they have been launched is very satisfying," says Peter Rothschild, President, BioGaia.    To Press release

Reuteri now sold in Russia
The launch of chewable tablets and drops withLactobacillus reuteri in Russia is well on its way. The sales force both in Moscow and St. Petersburg, are visiting doctors, clinics and pharmacies and also attending medical conferences and exhibitions. The advertising in magazines focusing on babies, children and young mothers is planned to start in March and is promoting both the tablets and the drops.
The products are sold by the Finnish company Verman under the brand name Relalife.
To Verman

Visit the new web site
BioGaia have developed a new platform for communications over the Internet for simplifying finding the information you are looking for. The new website is user-friendly with content and navigation clearly sorted by user groups: health care professionals, consumers, partners and investors.
Hopefully you will find the site both interesting and valuable. Do not hesitate to contact us if you have comments or questions. Your opinions are very valuable to us. 
To BioGaia

Valued dealership with Nippon Access in Japan
BioGaia has signed an exclusive dealership agreement with Japan's largest food and supplement wholesaler Nippon Access, a subsidiary of Japan's 5th largest trading company, Itochu Corporation.
"With the agreement we will be able to work through all possible distribution channels with almost all our products and reach consumers in a multitude of ways," says Peter Rothschild, President, BioGaia.
To Press release
  

Successful symposium in Latin America 
At LASPGHAN, Latin American Society of Paediatric Gastroenterology, Hepatology and Nutrition, BioGaia hosted a symposium in Puerto Varas, Chile together with its regional partnersRecalcine and Ferring Latin America.
Dr Flavia Indrio, University of Bari Policlinico, presented "Probióticos en Pediatria" including her findings on the gut motility and regurgitation studies on L. reuteri. The attendants showed a lot of interest both at the symposium and at the BioGaia booth. 
Dr Flavia Indrios findings

Attending ESPGHAN in Istanbul?
Are you planning to attend the Annual Meeting of ESPGHAN, European Society of Paediatric Gastroenterology, Hepatology and Nutrition, which will take place 9-12 June in Istanbul, Turkey? If so, you are most welcome to attend BioGaia's Satellite symposium "Probiotics in paediatrics - from evolution to clinical practice" on the 11th of June. Professor Yvan Vandenplas, Universitair Kinderziekenhuis, Brussels, Belgium, will chair the symposium.
To ESPGHAN